Skip to content

Evaluation of the curative effect of local injection of triamcinolone acetonide combined with oral prednisone in the prevention of postoperative esophageal stricture after ESD/ESTD

Evaluation of the curative effect of local injection of triamcinolone acetonide combined with oral prednisone in the prevention of postoperative esophageal stricture after ESD/ESTD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037434
Enrollment
Unknown
Registered
2020-08-28
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early esophagus cancer

Interventions

Experimental group:Local injection of triamcinolone acetonide combined with oral prednisone
Control group:Oral prednisone

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Patients with high-grade intraepithelial neoplasia or intramucosal carcinoma of the esophagus after ESD/ESTD in our hospital; 2) Mucosal defect after >=3/4 of whole esophagus after ESD/ESTD operation; 3) EUS and enhanced CT suggested no signs of peripheral lymph node metastasis or distant metastasis.

Exclusion criteria

Exclusion criteria: 1) Non-curative resection under endoscopy, requiring additional surgery, radiotherapy or chemotherapy; 2) There are contraindications to glucocorticoids (uncontrollable infection, active peptic ulcer, severe hypertension, poorly controlled diabetes, corneal ulcers, severe osteoporosis, adrenal hyperfunction, severe psychosis and Epilepsy, etc.); 3) Those who cannot insist on taking medication or have participated in other clinical research; 4) During pregnancy or lactation; 5) Severe heart, kidney, lung and liver diseases; 6) Those with poor compliance; 7) People with allergies, known or suspected of being allergic to the test drug.

Design outcomes

Primary

MeasureTime frame
Incidence of esophageal stricture;

Secondary

MeasureTime frame
Number of endoscopic treatments;Endoscopic intervention time;

Countries

China

Contacts

Public ContactJinlin Yang

West China Hospital, Sichuan University

mouse-577@163.com+86 18980602058

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026